Evidence map›Paper›PMID 29140482›Full record

ArticleBiostatistics (Oxford, England)2019

Estimating autoantibody signatures to detect autoimmune disease patient subsets.

Zhenke Wu, Livia Casciola-Rosen, Ami A Shah, Antony Rosen, Scott L Zeger

Open access · bronzeAbstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. SLE: reconciling heterogeneity.Lupus science & medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zhenke WuDepartment of Biostatistics and Michigan Institute of Data Science, University of Michigan, 1415 Washington Heights, Ann Arbor, MI, USA.
Livia Casciola-RosenDivision of Rheumatology, The Johns Hopkins University School of Medicine, Bayview Medical Center, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Baltimore, MD, USA.
Ami A ShahDivision of Rheumatology, The Johns Hopkins University School of Medicine, Bayview Medical Center, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Baltimore, MD, USA.
Antony RosenDivision of Rheumatology, The Johns Hopkins University School of Medicine, Bayview Medical Center, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Baltimore, MD, USA.
Scott L ZegerDepartment of Biostatistics, The Johns Hopkins University, 615 N Wolfe Street, Baltimore, MD, USA.
Johns Hopkins Bayview Medical Center · USJohns Hopkins University · USUniversity of Michigan–Ann Arbor · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Sample Processing and Immunoassay Research CoreP30AR070254 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI Antony Rosen · 2016 to 2026
$8.9M
Cancer, Autoantigens, and Scleroderma Investigating the ConnectionK23AR061439 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI SHAH, AMI AALOK · 2012 to 2016
$699k
NCI NIH HHS P30 CA046592NIAMS NIH HHS K23 AR061439NIAMS NIH HHS P30 AR070254
6 · The paper itself

Abstract

Autoimmune diseases are characterized by highly specific immune responses against molecules in self-tissues. Different autoimmune diseases are characterized by distinct immune responses, making autoantibodies useful for diagnosis and prediction. In many diseases, the targets of autoantibodies are incompletely defined. Although the technologies for autoantibody discovery have advanced dramatically over the past decade, each of these techniques generates hundreds of possibilities, which are onerous and expensive to validate. We set out to establish a method to greatly simplify autoantibody discovery, using a pre-filtering step to define subgroups with similar specificities based on migration of radiolabeled, immunoprecipitated proteins on sodium dodecyl sulfate (SDS) gels and autoradiography [Gel Electrophoresis and band detection on Autoradiograms (GEA)]. Human recognition of patterns is not optimal when the patterns are complex or scattered across many samples. Multiple sources of errors-including irrelevant intensity differences and warping of gels-have challenged automation of pattern discovery from autoradiograms.In this article, we address these limitations using a Bayesian hierarchical model with shrinkage priors for pattern alignment and spatial dewarping. The Bayesian model combines information from multiple gel sets and corrects spatial warping for coherent estimation of autoantibody signatures defined by presence or absence of a grid of landmark proteins. We show the pre-processing creates more clearly separated clusters and improves the accuracy of autoantibody subset detection via hierarchical clustering. Finally, we demonstrate the utility of the proposed methods with GEA data from scleroderma patients.

Indexed as

Autoimmune DiseasesModels, StatisticalPattern Recognition, AutomatedAutoantibodiesBayes TheoremBiostatisticsHumansImmunoprecipitationScleroderma, SystemicAutoantibodies

Identifiers

PMID29140482
PMCPMC6657300
OpenAlexW2963660102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.